Stéphanie Barrère-Lemaire held a position as research director at the Centre National de la Recherche Scientifique (CNRS).
From 1994 to 1997, she followed a PhD program at the Faculty of Medicine of Montpellier. She completed her thesis “Pathophysiology of calcium channels activated by voltage in human cardiac cells”.
In 1997, she joined Dr K. Chien’s laboratory at the University of California in San Diego as postdoctoral fellow in order to explore the mechanisms of sudden death (Nguyêñ-Trân et al, Cell 2000). From there, she returned in France as a senior researcher at the CNRS (1998).
Since, the study of ischemia-reperfusion injury during myocardial infarction is the main research topic of her group with projects aiming to study the cell death pathways and cardioprotection mechanisms to find new therapeutic strategies to inhibit ischemia-reperfusion injury (Roubillle et al, Circulation 2007 and 2011; Boisguerin et al, Cardiovasc Res 2020).
Since 2011, she leads the “Cardioprotection, physiopathology of heart rhythm and ischemia” team with Dr M. Mangoni, PhD, in the Department of Physiology and Cancer of the Institute of Functional Genomics, Montpellier-France with their research projects focused on cardioprotection.
Stéphanie Barrère-Lemaire held a position as research director at the Centre National de la Recherche Scientifique (CNRS).
From 1994 to 1997, she followed a PhD program at the Faculty of Medicine of Montpellier. She completed her thesis “Pathophysiology of calcium channels activated by voltage in human cardiac cells”.
In 1997, she joined Dr K. Chien’s laboratory at the University of California in San Diego as postdoctoral fellow in order to explore the mechanisms of sudden death (Nguyêñ-Trân et al, Cell 2000). From there, she returned in France as a senior researcher at the CNRS (1998).
Since, the study of ischemia-reperfusion injury during myocardial infarction is the main research topic of her group with projects aiming to study the cell death pathways and cardioprotection mechanisms to find new therapeutic strategies to inhibit ischemia-reperfusion injury (Roubillle et al, Circulation 2007 and 2011; Boisguerin et al, Cardiovasc Res 2020).
Since 2011, she leads the “Cardioprotection, physiopathology of heart rhythm and ischemia” team with Dr M. Mangoni, PhD, in the Department of Physiology and Cancer of the Institute of Functional Genomics, Montpellier-France with their research projects focused on cardioprotection.